Anti-platelet factor 4/heparin antibodies in patients with impaired graft function after liver transplantation.
about
Heparin-induced thrombocytopenia in solid organ transplant recipients: The current scientific knowledgeThe unique immunological features of heparin-induced thrombocytopenia.CXCL4 Contributes to the Pathogenesis of Chronic Liver Allograft Dysfunction.Thrombocytopenia after liver transplantation: Should we care?
P2860
Anti-platelet factor 4/heparin antibodies in patients with impaired graft function after liver transplantation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Anti-platelet factor 4/heparin ...... n after liver transplantation.
@ast
Anti-platelet factor 4/heparin ...... n after liver transplantation.
@en
type
label
Anti-platelet factor 4/heparin ...... n after liver transplantation.
@ast
Anti-platelet factor 4/heparin ...... n after liver transplantation.
@en
prefLabel
Anti-platelet factor 4/heparin ...... n after liver transplantation.
@ast
Anti-platelet factor 4/heparin ...... n after liver transplantation.
@en
P2093
P2860
P356
P1476
Anti-platelet factor 4/heparin ...... n after liver transplantation.
@en
P2093
A Greinacher
E Matevossian
T Bakchoul
P2860
P304
P356
10.1111/JTH.12569
P577
2014-06-01T00:00:00Z